Unveiling the benefts of Vitamin D3 with SGLT-2 inhibitors for hypertensive obese obstructive sleep apnea patients
Background Obstructive sleep apnea (OSA) is associated with poorer quality of life (QoL) and increased cardiovascular risks, which may be exacerbated by hypovitaminosis D. Sodium glucose transporter-2 inhibitor (SGLT2i) provides cardiovascular benefts beyond glycemic control. As vitamin D3 and SGLT...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | en |
| Published: |
BioMed Central Ltd.
2025
|
| Subjects: | |
| Online Access: | http://ir.unimas.my/id/eprint/47737/1/Unveiling%20the%20benefits.pdf http://ir.unimas.my/id/eprint/47737/ https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06312-w#:~:text=This%20is%20the%20first%20study,QoL%20in%20this%20patient%20population. https://doi.org/10.1186/s12967-025-06312-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
http://ir.unimas.my/id/eprint/47737/1/Unveiling%20the%20benefits.pdfhttp://ir.unimas.my/id/eprint/47737/
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06312-w#:~:text=This%20is%20the%20first%20study,QoL%20in%20this%20patient%20population.
https://doi.org/10.1186/s12967-025-06312-w
